Publication | Open Access

Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study

Hematological MalignancyMedicineAcute Myeloid LeukemiaHematologyPharmacologyInduction TreatmentPharmacotherapyOncologyPhase Iii StudyCancer ResearchMyeloid Neoplasia